ReleaseWire

GlobalData's clinical trial report, "Ocular Pain Global Clinical Trials Review, H2, 2014" provides data on the Ocular Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'IntelGenx Corp. - Product Pipeline Review - 2014', provides an overview of the IntelGenx Corp.'s pharmaceutical research and development focus.

Many individuals in different areas worldwide are suffering from arthritic conditions. Due to the increasing number of people who have arthritis, many companies also produce a variety of treatment options for sufferers to choose from. Pharmaceutical companies have been producing NSAIDs while others offer natural alternatives such as glucosamine supplements.

Due to the vast amounts of people suffering from Vitamin D3 deficiency, Natures True Medicine recently launched their new vitamin D3 2000iu supplement. Formulated with 100% natural ingredients to help users maintain optimal levels of this important vitamin, their vitamin D3 2000iu supplement has been met with instantaneous success and affirmative feedback by customers.

GlobalData's clinical trial report, "Schizoaffective Disorder Global Clinical Trials Review, H2, 2014" provides data on the Schizoaffective Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Schizoaffective Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Schizoaffective Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'NanoCarrier Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the NanoCarrier Co., Ltd.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2014" provides data on the Relapsing Remitting Multiple Sclerosis (RRMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsing Remitting Multiple Sclerosis (RRMS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Relapsing Remitting Multiple Sclerosis (RRMS). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

GlobalData's clinical trial report, "Periventricular Leukomalacia Global Clinical Trials Review, H2, 2014" provides data on the Periventricular Leukomalacia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Periventricular Leukomalacia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Periventricular Leukomalacia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Psychosis Global Clinical Trials Review, H2, 2014" provides data on the Psychosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psychosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Psychosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Brain Cancer - Pipeline Review, H2 2014', provides an overview of the Brain Cancer's therapeutic pipeline.

Global Markets Direct's, 'International Stem Cell Corporation - Product Pipeline Review - 2014', provides an overview of the International Stem Cell Corporation's pharmaceutical research and development focus.

GlobalData's clinical trial report, "Seizures Global Clinical Trials Review, H2, 2014" provides data on the Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Marina Biotech, Inc. - Product Pipeline Review - 2014', provides an overview of the Marina Biotech, Inc.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014" provides data on the Oppositional Defiant Disorder (ODD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oppositional Defiant Disorder (ODD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oppositional Defiant Disorder (ODD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Microbio Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Microbio Co., Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'reMYND - Product Pipeline Review - 2014', provides an overview of the reMYND's pharmaceutical research and development focus.

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Turkey. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Inbiopro Solutions Pvt. Ltd. - Product Pipeline Review - 2014', provides an overview of the Inbiopro Solutions Pvt. Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'NuCana BioMed Limited - Product Pipeline Review - 2014', provides an overview of the NuCana BioMed Limited's pharmaceutical research and development focus.

Global Markets Direct's, 'Nyken BV - Product Pipeline Review - 2014', provides an overview of the Nyken BV's pharmaceutical research and development focus.

GlobalData's clinical trial report, "Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014" provides data on the Obsessive-Compulsive Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Obsessive-Compulsive Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Obsessive-Compulsive Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Fallopian Tube Cancer - Pipeline Review, H2 2014', provides an overview of the Fallopian Tube Cancer's therapeutic pipeline.

Global Markets Direct's, 'Hodgkin Lymphoma - Pipeline Review, H2 2014', provides an overview of the Hodgkin Lymphoma's therapeutic pipeline.